๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pamidronate increases markers of bone formation in patients with multiple myeloma in plateau phase under interferon-alpha treatment

โœ Scribed by E. Terpos; J. Palermos; N. Viniou; G. Vaiopoulos; J. Meletis; X. Yataganas

Book ID
105558337
Publisher
Springer
Year
2001
Tongue
English
Weight
551 KB
Volume
68
Category
Article
ISSN
1432-0827

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The addition of interferon or high dose
The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma : Phase III Eastern Cooperative Oncology Group clinical trial EST 9486
โœ Martin M. Oken; Traci Leong; Raymond E. Lenhard Jr.; Philip R. Greipp; Neil E. K ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 133 KB ๐Ÿ‘ 2 views

## BACKGROUND. Interferon (IFN) has demonstrated activity in the treatment of patients with multiple myeloma. A previous Eastern Cooperative Oncology Group (ECOG) study suggested that the rates of complete response (CR) and survival were increased with a regimen that alternated IFN with chemothera